Log In
Print
BCIQ
Print
Print this Print this
 

Acetadote, acetylcysteine

  Manage Alerts
Collapse Summary General Information
Company Cumberland Pharmaceuticals Inc.
DescriptionIntravenous acetylcysteine
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPoisoning
Indication DetailsTreat acetaminophen poisoning; Treat non-acetaminophen induced acute liver failure
Regulatory Designation
Partner Harbin Gloria Pharmaceuticals Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today